You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Zytiga

Showing 1 - 25 of 123
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Seoul (SOL-804-F, Zytiga)

Recruiting
  • Prostate Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 25, 2023

Abiraterone Acetate in Indian Metastatic, Castration Resistant

Withdrawn
  • Prostate Cancer
  • Abiraterone Acetate
  • Bangalore, India
  • +2 more
Aug 15, 2022

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial in Shanghai (Abiraterone Acetate Tablets (I), ZYTIGA®)

Completed
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 16, 2022

Learn About Novel Hormonal Therapies for Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Nov 21, 2023

Prostate Cancer Trial in Tampa (Abiraterone Acetate)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 3, 2023

Learn About Novel Hormonal Therapies in People With Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Oct 2, 2023

Prostate Cancer Metastatic Trial (MK-5684, Abiraterone acetate, Enzalutamide)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Nov 21, 2023

Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate, Placebo, Hydrocortisone)

Withdrawn
  • Congenital Adrenal Hyperplasia
  • Abiraterone acetate
  • +3 more
  • Los Angeles, California
  • +3 more
Jan 30, 2023

Medicines Called Enzalutamide and Abiraterone in People With

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • New York, New York
    Pfizer Inc
Jul 21, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Prostatic Neoplasms
  • (no location specified)
Nov 21, 2023

NSCLC Harboring NRG1 Fusion, Metastatic Castration-resistant Prostate Cancer Trial in Whittier, Lake Mary (Afatinib Oral Tablet,

Recruiting
  • NSCLC Harboring NRG1 Fusion
  • Metastatic Castration-resistant Prostate Cancer
  • Afatinib Oral Tablet
  • +3 more
  • Whittier, California
  • +1 more
Dec 20, 2022

Metastatic Castration-resistant Prostate Cancer Trial (Abiraterone Acetate)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Abiraterone Acetate
  • (no location specified)
Apr 19, 2022

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,

Active, not recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Los Angeles, California
  • +6 more
Jan 18, 2023

Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)

Recruiting
  • Prostate Cancer Metastatic
  • Prostate Cancer
  • Houston, Texas
  • +2 more
Oct 7, 2022

Prostatic Tumors, Castration-Resistant Trial in Leiden (Patient-specific adaptive therapy, Abiraterone acetate, Enzalutamide)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Patient-specific adaptive therapy
  • +2 more
  • Camperdown, New South Wales, Australia
  • +6 more
Jan 11, 2023

Prostatic Tumors Trial in New York (CC-90011, Abiraterone, Prednisone)

Recruiting
  • Prostatic Neoplasms
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 21, 2022

Urothelial Carcinoma, Bladder Cancer Trial in Houston (Abiraterone acetate, Durvalumab, Methotrexate)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Abiraterone acetate
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 2, 2022

Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial (Abiraterone Oral Tablet, Prednisone tablet, Drug Dairy/Log)

Not yet recruiting
  • Prostate Cancer
  • +3 more
  • Abiraterone Oral Tablet
  • +3 more
  • (no location specified)
Apr 1, 2022

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Prostate Cancer Trial in Washington, Baltimore (Leuprolide Acetate, Docetaxel, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +1 more
Mar 29, 2022

Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate)

Active, not recruiting
  • Congenital Adrenal Hyperplasia
  • Abiraterone acetate
  • Los Angeles, California
  • +3 more
Feb 22, 2022

Newly Diagnosed Oligometastatic Prostate Cancer Trial in Long Beach, West Los Angeles, Richmond (procedure, radiation, drug)

Active, not recruiting
  • Newly Diagnosed Oligometastatic Prostate Cancer
  • radical prostatectomy
  • +4 more
  • Long Beach, California
  • +2 more
Mar 16, 2022

Metastatic Castrate-Resistant Prostate Cancer Treated With

Completed
  • Prostate Cancer
  • Durham, North Carolina
    Duke University Medical Center
Dec 22, 2020

Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Baltimore, Maryland
  • +3 more
Mar 30, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Atlanta, Minneapolis, Nashville (Rucaparib, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Atlanta, Georgia
  • +2 more
Jan 24, 2022